Press Release

Wanbury Limited R~d. Office : BSEL Tech Park, B-wing 10' Floor, Sector-30 A, Opp. Vashi Railway Station, Vashi Navi Mumbai 400 703 Maharashtra, INDIA Tel. : +91-22-6794 2222 ( WAN BURY +91-22-7196 3222 CIN L51900MH1988PLC048455 Email : info@wanbury.c:om Website: www.wanbury.com October 08, 2026 BSE Limited National Stock Exchange of India Ltd, PJ. Towers, Exchange Plaza, Dalal Street Bandra Kurla Complex, Mumbai-400 001. Bandra (East), Mumbai -400 051. Script Code: 524212 Script Code: W ANBURY Dear Sir/Madam, Sub.:Press Release regarding filing new Drug Master File (DMF) in South Africa for Tramadol HCI APL Pursuant to Regulation 30 of SEBI LODR, we wish to inform you as under: W anbury Limited continued to expand business opportunities by filing new Drug Master File (DMF) in South Africa for Tramadol HCl APL In addition, company filed DMF in Philippines and Singapore for Metformin HCl API to meet customer expectations. Company added additional Key Starting Materials (KSM) vendors to ensure supply chain continuity for its CEP filed API, Paroxetine HCl and received approval from the office of European Directorate for the Quality of Medicines and Healthcare (EDQM). Therapeutic Goods Administration (TGA) accepted the compliance report for the inspectional observations; which will enable company to continue supply of its best quality APis for Australia market. This is for your information and record. Thanking you. Yours faithfully, For Wanbury Limited Jitendra J. Gandhi Company Secretary